Last October, Grey Cloak Tech (OTCQB: GRCK) entered the CBD market sector through its acquisition of Eqova Life Sciences, an established producer of a wide range of clinical-grade hemp CBD oil products supplying medical practitioners. An article discussing the company reads: “Eqova’s products are not developed for recreational use, and the company only uses natural, standardized phytocannabinoid-rich hemp oil in its medical-grade, CBD-based products. It employs a rigorous product development cycle, where each ingredient is studied in isolation and in the context of other ingredients, use case and delivery method. Eqova has developed cutting-edge delivery methods for oral, topical, liposomal and sublingual applications. The company’s innovative products and commitment to stringent quality control ensures that medical practitioners receive high quality, consistent pharmaceutical-grade ingredients with standardized dosing to help their patients.”
To view the full article, visit http://ibn.fm/yutyO
Let us hear your thoughts: Grey Cloak Tech, Inc. Message Board
About Grey Cloak Tech Inc.
Grey Cloak Tech (OTCQB: GRCK) is the parent company of CBD.co as well as Eqova Life Sciences, which is a practitioner line of CBD products sold exclusively to licensed medical professionals. For more information, visit the company’s website at www.GreyCloakTech.com.
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.